International Psoriasis Council
Advancing Knowledge. Improving Care.
What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and
Palmoplantar pustulosis (PPP) is a challenging inflammatory skin disease often misclassified as psoriasis. Dr. José-Manuel Carrascosa Carrillo shares clinical perspectives
Learn how psoriasis connects to psoriatic arthritis, cardiovascular disease, obesity, and mental health in IPC’s World Psoriasis Day 2025 campaign.
At the 2025 EADV Annual Meeting in Paris, experts shared new insights into psoriasis diagnosis, symptoms, and treatment. Highlights include
IPC publishes a global review highlighting the physical, emotional, and family burden of pediatric psoriasis. Read the full findings and
The updated IPC psoriasis severity classification gains broader clinical and global acceptance, emphasizing impact over body surface area, and growing
The World Health Assembly has adopted a resolution recognizing skin diseases, including psoriasis, as a global public health priority. This
Learn about the relationship between psoriasis, obesity, and systemic inflammation, and how GLP-1 agonists, originally developed for type 2 diabetes
National cohort data from Taiwan reveal a strong link between immune checkpoint inhibitor (ICI) therapy and new-onset psoriasis in cancer
Discover the new free psoriasis course on WHOAcademy, created by IPC and IFPA for the WHO. Enhance your knowledge of
Learn about the relationship between psoriasis, obesity, and systemic inflammation, and how GLP-1 agonists, originally developed for type 2 diabetes
The 2025 AAD Annual Meeting featured important updates on psoriasis therapies, comorbidities, and late-breaking research. Read the highlights from top
This article examines the unique impact of psoriasis on individuals assigned female at birth, particularly during pregnancy and menopause, highlighting
The Psoriasis: From Gene to Clinic Congress Report highlights breakthroughs in genetics, clinical care, and treatment advancements for psoriasis, featuring
This article examines the unique impact of psoriasis on individuals assigned female at birth, particularly during pregnancy and menopause, highlighting
The 2024 Society for Investigative Dermatology (SID) Annual Meeting was held from May 14 to 18, 2024, in Dallas, Texas,
Uncover the true impact of psoriasis and learn about critical steps to improve diagnosis, treatment, and patient support in the
Psoriasis in older patients presents unique challenges and treatment considerations. Learn about the prevalence of topical therapies, phototherapy, and systemic
Read key highlights from the 2023 International Psoriasis Council (IPC) Think Tank Meeting, summarizing the evolving understanding of psoriasis management,
Learn from Dr. Steven Feldman, a renowned expert in psoriasis treatment, about the importance of patient adherence. Discover practical strategies
Access the latest insights from the 32nd European Academy of Dermatology and Venereology 2023 Congress (EADV) in Berlin, Germany. This
IPC stands for accessible treatment and universal healthcare on World Psoriasis Day and beyond. Gain insights from experts on the
Explore the challenges, solutions, and breakthroughs in improving psoriasis treatment adherence. Discover the latest strategies and steroid-free topical agents transforming
The IPC is proud to announce a collaboration with the National Psoriasis Foundation (NPF) in unveiling new insights into the
In this enlightening blog post, Dr. Andrew Alexis, an esteemed Professor of Clinical Dermatology, delves into the intricacies of diagnosing
Discover the latest insights on psoriasis treatment for individuals with skin of color in our comprehensive blog post. Learn about
This blog post provides a comprehensive overview of psoriasis in individuals with skin of color. It explores the prevalence of
The European Academy of Dermatology and Venereology (EADV) organized its 31st congress in Milano, Italy, under the parole “Designing the
Prof. Christine Bundy shares how clinicians can center mental health in psoriasis care — and what to look out for
Researchers at Cardiff University have created and launched The Official DLQI App, designed to measure the quality of life for
In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.
What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.
The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.
In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.